NorthStar Medical Radioisotopes Logo

NorthStar Medical Radioisotopes

Company | NorthStar Medical Radioisotopes, LLC

Who is NorthStar Medical Radioisotopes?

We are routinely producing Copper-67 (Cu-67), used in clinical trials for the treatment of several types of cancer. We are dedicated to preserving the environment using non-uranium production methods. We are pioneers working with industry leaders to develop and commercialize new diagnostics and radiopharmaceutical therapies that will serve the next generation of medical advances for patients. NorthStar is a radiopharmaceutical company, developing novel ways to help detect and cure cancer and other serious diseases. The next major horizon includes a world class Radiopharmaceutical CDMO/CMO, launching production operations in early 2025. Our executive team brings proven experience and expertise in developing and commercializing innovative nuclear medicine products and technologies. We’ve developed Cu-67 and Ac-225 production processes that are non-reactor based. NorthStar’s patient-focused Radiopharmaceutical Contract Development and Manufacturing Organization (CDMO/CMO) addresses this important need.

This company is:

Manufacturer

Madison, United States

51-100 Employees

Founding year: 2006



Products & services of NorthStar Medical Radioisotopes

Product NNSA awards NorthStar Medical Technologies a Cooperative Agreement to Produce Critical Medical Isotope | NorthStar Medical Radioisotopes, LLC image
Product

Verified

NNSA awards NorthStar Medical Technologies a Cooperative Agreement to Produce Critical Medical Isotope | NorthStar Medical Radioisotopes, LLC

MADISON, WI – November 21, 2013 – NorthStar Medical Technologies, LLC (“NorthStar”), today announced it was awarded a $21.8 million cooperative agreement of which $10.9 million will be funded by the Department of Energy’s (DOE) National Nuclear Security Administration (NNSA). The cooperative agreement is part of the NNSA’s Global Threat Reduction Initiative, which aims to […]

Product NorthStar and its Future with Electron Accelerator Technology | NorthStar Medical Radioisotopes, LLC image
Product

Verified

NorthStar and its Future with Electron Accelerator Technology | NorthStar Medical Radioisotopes, LLC

NorthStar Medical Radioisotopes is poised to become the first-in-class production supply chain for the future of therapeutic radiopharmaceuticals. In September 2019, the company broke ground on a 30,000 ft. building that now houses the company’s first pair of electron beam accelerators. This past September 2021, the company celebrated the successful installation of the accelerators as […]

Product NorthStar Medical Radioisotopes Expansion Event Unveils Advanced Radioisotope Production Equipment and Breaks Ground on First-in-Kind Therapeutic Radioisotope Production Facility | NorthStar Medical Radioisotopes, LLC image
Product

Verified

NorthStar Medical Radioisotopes Expansion Event Unveils Advanced Radioisotope Production Equipment and Breaks Ground on First-in-Kind Therapeutic Radioisotope Production Facility | NorthStar Medical Radioisotopes, LLC

− Marking Company’s progress in advancing innovative and environmentally sound production of diagnostic imaging and therapeutic radioisotopes for the United States and Wisconsin − BELOIT, Wis., October 14, 2021 – NorthStar Medical Radioisotopes, LLC, a global innovator in the development, production and commercialization of radiopharmaceuticals used for medical imaging and therapeutic applications, hosted a growth […]

View all products


Keywords

Hospitality
Pharmaceuticals
Health Diagnostics
Pharmaceutical
Therapeutics
Health Care

Industries

Pharmaceuticals

Use Cases of NorthStar Medical Radioisotopes

text-slider-1

BioForward Announces Winners of 2011 Bioscience Vision Summit's Emerging Company Showcase | NorthStar Medical Radioisotopes, LLC

MADISON, Wis.–(BUSINESS WIRE)–Six Wisconsin bioscience companies have been selected as the winners of BioForward’s 2011 Emerging Company Showcase.  Read more…


Contact of NorthStar Medical Radioisotopes

City: Madison

State: Wisconsin

Country: United States



Frequently asked questions (FAQ) about NorthStar Medical Radioisotopes

The company NorthStar Medical Radioisotopes is located in Madison, Wisconsin, United States. It's worth noting that the company may has more corporate locations

As of the latest available information NorthStar Medical Radioisotopes has around 51-100 employees worldwide.

NorthStar Medical Radioisotopes was founded in 2006

The company NorthStar Medical Radioisotopes has it's main focus in the industries of Pharmaceuticals

Based on the founding year and the amount of employees the company NorthStar Medical Radioisotopes seems to be a Medium-Sized Company at the current state. Note that over time that status can change

Competitors of NorthStar Medical Radioisotopes

Point Biopharma Logo

Point Biopharma

United States

11-50 Employees

2017

View

Niowave Logo

Niowave

United States

101-250 Employees

2005

View

Applied Molecular Therapies Logo

Applied Molecular Therapies

Australia

51-100 Employees

2021

View

Northwest Medical Isotopes Logo

Northwest Medical Isotopes

United States

1-10 Employees

2010

View

Fusion Pharmaceuticals Logo

Fusion Pharmaceuticals

Canada

11-50 Employees

2014

View

AREVA Med LLC Logo

AREVA Med LLC

United States

11-50 Employees

View

IsoRay Logo

IsoRay

United States

11-50 Employees

1998

View

ARTMS Logo

ARTMS

Canada

11-50 Employees

2013

View


Suitable topics for NorthStar Medical Radioisotopes

Topics which have been searched by others and may be interesting for you: